| Net income | 274.37M |
| Depreciation and amortization | 16.59M |
| Excess income tax benefit from exercise of stock options | -10.95M |
| Equity-based compensation expense | 32.46M |
| Contract land deposit impairments (recoveries) | |
| Gain on sales of loans | -59.39M |
| Mortgage loans closed | -2.54B |
| Proceeds from sales of mortgage loans | 2.63B |
| Principal payments on mortgage loans held for sale | |
| Distribution of earnings from unconsolidated joint ventures | |
| Increase in inventories | -309.82M |
| Increase in contract land deposits | -32.77M |
| Increase in receivables | -2.91M |
| Increase in accounts payable, accrued expenses and customer deposits | |
| Other, net | |
| Net cash used in operating activities | |
| Purchase of marketable securities | |
| Redemption of marketable securities at maturity | |
| Investments in and advances to unconsolidated joint ventures | -653K |
| Distribution of capital from unconsolidated joint ventures | |
| Purchase of property, plant and equipment | -16.51M |
| Proceeds from the sale of property, plant and equipment | 701K |
| Net cash (used in) provided by investing activities | |
| Purchase of treasury stock | -291.74M |
| Net (repayments) borrowings under notes payable and credit lines | |
| Redemption of senior notes | |
| Net repayments under non-recourse debt related to consolidated variable interest entity | |
| Excess income tax benefit from equity based compensation | 10.95M |
| Exercise of stock options | 33.94M |
| Net cash used in financing activities | |
| Net decrease in cash and cash equivalents | -162.89M |
| Cash and cash equivalents, beginning of the period | 425.32M |
| Cash and cash equivalents, end of period | 262.43M |
| Interest paid during the period, net | 20.9M |
| Income taxes paid, net of refunds | 148.12M |
| Investment in consolidated joint venture | |